Gainers
- Unicycive Therapeutics UNCY shares rose 27.9% to $1.65 during Thursday's after-market session. The company's market cap stands at $24.7 million.
- Clearside Biomedical CLSD stock increased by 15.06% to $1.68. The company's market cap stands at $100.2 million.
- Cingulate CING shares increased by 12.49% to $1.35. The company's market cap stands at $15.2 million.
- Aerie Pharmaceuticals AERI stock moved upwards by 8.47% to $6.4. The company's market cap stands at $303.0 million. As per the news, the Q4 earnings report came out today.
- Silk Road Medical SILK stock rose 7.69% to $34.0. The company's market cap stands at $1.1 billion. As per the news, the Q4 earnings report came out today.
- Avalon Globocare AVCO stock moved upwards by 5.83% to $0.78. The market value of their outstanding shares is at $68.9 million.
Losers
- Pulmatrix PULM stock fell 15.7% to $0.32 during Thursday's after-market session. Pulmatrix's trading volume hit 423.4K shares by close, accounting for 40.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $17.7 million.
- Dermata Therapeutics DRMA shares decreased by 11.67% to $1.06. The market value of their outstanding shares is at $8.8 million.
- Virpax Pharmaceuticals VRPX stock fell 11.22% to $1.82. The market value of their outstanding shares is at $21.3 million.
- OPKO Health OPK shares declined by 8.98% to $2.94. At the close, OPKO Health's trading volume reached 104.9K shares. This is 1.9% of its average volume over the last 100 days. The company's market cap stands at $2.0 billion. As per the news, the Q4 earnings report came out today.
- Tabula Rasa HealthCare TRHC stock decreased by 7.71% to $4.31. The company's market cap stands at $110.8 million. As per the news, the Q4 earnings report came out today.
- Histogen HSTO stock declined by 6.43% to $0.22. The market value of their outstanding shares is at $10.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in